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Biography  
Dr. Pamela Hinds PhD, RN, FAAN, is the Executive Director of the Department of 
Nursing Science, Professional Practice, and Quality, and Professor of Pediatrics at the 
George Washington University.  She is currently serving on the National Academies of 
Sciences, Engineering and Medicine (NASEM) Roundtable on Quality Care for People 
with Serious Illness and the NASEM Committee on Childhood Cancers and Disability.  
Her expansive research career has focused on the pediatric cancer experience and quality 
of life. Dr. Hinds has authored and edited over 400 journal articles and book chapters and 
continues to advance the field of pediatric palliative care.  
 
Interview Abstract  
Dr. Pamela Hinds begins by identifying some early experiences in her nursing career that 
led her towards a career in pediatric palliative care. She recalls some of the challenges of 
funding research and reframing some of the discipline’s stigma around child-death from 
“physician failure” to a patient and family-informed process of the bio-psycho-social 
changes that were happening to the child. Dr. Hinds goes on to describe some of the 
successes in pediatric palliative care being the cultivation of the multi-disciplinary then 
interdisciplinary team approach as well as the changes in the relationship between 
providers and families.  Dr Hinds describes the on-going challenges in pediatric palliative 
care being credibility, funding, and policy, but she relays her excitement to continue to 
help develop this specialty into a vision of patient-first advocacy and patient choice. 
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[00:00:00] 
Bryan Sisk: Today is April 19, 2019. I am Bryan Sisk, and I am in St. Louis, 
Missouri interviewing Dr. Pamela Hinds over the telephone for the 
Pediatric Palliative Care Oral History Project. Dr. Hinds is in 
Washington DC. Thank you, Dr. Hinds, for joining me today. To 
get started, could you just tell me when did your mind turn toward 
pediatric palliative care as a potential career focus?  
 
Pamela Hinds: My first exposure was when I was a nursing student and I was 
working with a little boy who had leukemia. At that time, it was a 
fatal illness. This was in the 60s and 70s. It was a sobering 
experience for me as a very young woman, new to the profession, 
to be caring so much about a little one who was not going to 
survive. In particular one day, I had missed him. I'd been off the 
unit and away from patient care for a couple of days and when I 
came back it was very clear to me he had lost ground. He reached 
out to me wanting me to hold him and I stepped right into holding 
him, but the way I picked him up hurt him.  
 
The thought that I could cause a child pain, oh, was really 
horrendous for me. That made me think about dedicating time and 
effort towards relieving pain and other symptoms that a child 
might have when so, so ill. That got me started and at that time the 
philosophy was that you really needed to have experience in 
palliative care, and so I did begin. I had time in an emergency 
room, nursing time in critical care and then my graduate program I 
wanted to focus on how to create an environment of care that 
would be gentle for children. Then went on to my doctoral study 
some years later, many years later, because I really wanted to look 
at hope and how it was that we as clinicians, particularly nurses, 
might be able to foster hope in children and adolescents who were 
quite, quite ill. That's how I got started.  
[00:02:26] 
 Bryan Sisk: When you were starting out, did you find a community of similar 
minds on the subject? 
 
Pamela Hinds: No, we really didn't. In fact, people often thought it was hard 
enough to be a clinician dealing with children who did not feel 
well, but quite hard to be with a child who might not get better. 
That was the sense that people had at the time was yeah, but this 
child might never get better. No, we didn't find many likeminded 
people, and I have to say it made me self-conscious about what I 
was choosing to do and what I was looking at. I had to really 
question myself about that.  
[00:03:12] 
 Bryan Sisk: Did other people externally question you?  
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Pamela Hinds: Yes. Family members, friends, professionals all suggested it would 
be very likely more worthwhile if I focused my career on children 
who were going to recover, children who could become well again. 
I think people honestly felt protective of a young person in a new 
career that focusing on something so sad might turn the career in a 
direction that would be sad too. I think it was a protective effort 
based on the real belief that children did not get better.  
[00:04:01] 
 Bryan Sisk: What was it like to be essentially alone in the early steps?  
 
Pamela Hinds: I think as a young professional, I was doing multiple things at the 
same time that all were related to palliative care, but they were not 
as—now they would fit the definition of palliative care, but at that 
time palliative care was very much defined as end-of-life only. I'm 
sure that it would've looked to other people as if I was doing a 
blend of activities that were not necessarily moving in the same 
direction. Using today's definition, they would have all been seen 
as palliative care. We've just developed a broader definition these 
days.  
[00:05:02] 
 Bryan Sisk: Along this journey, when did you first start to find others who 
cared about the same work and the same issues?  
 
Pamela Hinds: I think it was in the 1980s and it was very exciting. That became 
more pronounced, most definitely in the late 1990s, and then we 
really had a widening circle. For me, I had been educated on the 
undergraduate and at the graduate level, to really believe in 
interprofessional care. For me, I honestly believed, still do, that the 
best care is given by a team of diverse disciplines and for me the 
best research is that way, then the best—sorry, the best care is that 
way then the best research should be that way as well. That helped 
me to really seek out interprofessional opportunities and 
colleagues. I really think that is the way to live. I think 
professionally it's so exciting to live that way.  
[00:06:07] 
 Bryan Sisk: Who did you learn from or how did you learn when there weren't a 
lot of people doing this in the late 60s and early 70s? 
 
Pamela Hinds: I think we learned from people in specialties where there was a 
high death rate. For me that was critical care. That was the 
emergency room and it was pediatric oncology. You sought 
colleagues and we had quite a discussion about taking care of the 
suffering child, taking care of yourself very quietly. How would 
we do that?  
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Then when I finished my doctoral studies in 1985 and then went to 
St. Jude Children's Research Hospital where I spent the next two 
decades and found a whole host of kindred spirits. That was part of 
the excellence of that time period and certainly of those 
individuals. I remember creating different studies and always 
having a translation piece to that: a piece that would go to the 
parents, the piece that would go to our children, and the piece that 
would go to clinicians. These were incredibly well received, but 
we also did experiential offerings and one was about the meaning 
of being a pediatric oncology specialist. One was about having 
hope in serious situations and one was about mistake making. I'd 
have to say those are examples.  
 
We did grief workshops and other kinds of things, but I would 
honestly say to you probably the best attended was mistake 
making. I honestly believe that we all feel quite badly about 
making a mistake —I just think we're all very conscientious 
people. It's horrifying enough to make a mistake - period, but it's 
particularly horrifying if it's with a child whose life is ending soon. 
You want so badly to do well by that child, and it may be your last 
chance to do well by that child. I think that makes it incredibly 
more complicated frankly, yeah.  
[00:08:40] 
 Bryan Sisk: Speaking of St. Jude, or really any tertiary academic medical 
center, a lot of times parents are coming for a cure. St. Jude is the 
patron saint of lost causes or last chances. What was your 
experience coming into a situation where people might have 
viewed death as a failure as opposed to a natural end?  
 
Pamela Hinds: I think I experienced that commonly, even amongst individuals 
who were seasoned. I think it was very difficult for a number of 
my physician colleagues to see it as anything but a failure. 
Concerningly for me, they honestly thought that those of us around 
them thought that, too, about them. Truthfully, we never did. It was 
very hard to convince physician colleagues that no one saw them 
as having failed that child and I can remember having very direct, 
very honest conversation with senior physicians at St. Jude 
Children's Research Hospital about why we did not see it that way. 
How comforting that was for them because they honestly believed 
we must have thought less of them.  
[00:10:12] 
 Bryan Sisk Have you seen that change over time or has that stayed the same?  
 
Pamela Hinds: I have seen that change over time, but I would say to you quite 
honestly, there are still physician colleagues who suffer from that, 
and I do mean suffer. Yeah. I know that when for example I had 
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done end-of-life studies, palliative care studies, most times we've 
had a three-step process confirming eligibility of the family before 
we ever approach the family. The first step is to check in with the 
attending to make sure that the family could at this point fully 
understand that this is a research study that I'm approaching them 
about, that they have the right to refuse and that it wouldn't be too 
emotionally burdensome for them. Almost always my physician 
colleagues have said, "Yes, you could approach this family. They 
would meet those criteria."  
 
Also, almost always there would be a gentle smile and the 
physician would say, "I know you said you're only studying the 
family, but aren't you really studying me, how I do palliative 
care?" Truthfully Bryan, we've never done that. That's never been a 
part of our studies. I think that even when our physician colleagues 
don't say that they suffer from that, they likely do, or they may. I 
guess it's at least a risk. Yeah.  
[00:11:50] 
 Bryan Sisk: Thinking back to when you were starting out, how do you think 
clinicians at that time understood a child suffering?  
 
Pamela Hinds: In my early days of being a nurse, those were the days when you 
still had a written medical order that said, "Do not tell the child the 
diagnosis. If the child speaks of being worried, comfort the child 
and that things are going to get better." We were one of the 
earliest, probably, groups that benefitted from the research and 
done by Glaser, Strauss and Benoliel about awareness of dying.1 
These pioneers were DRs. Barney Glaser, Anselm Strauss, and 
Jeanne Quint Benoliel.  
 
They studied settings where the patients knew that they were 
seriously ill, but they did not want it to be spoken of, because they 
worried that by speaking of their deteriorating condition, they 
would make their families uncomfortable, and they didn't want to 
do that. We then benefitted from this research finding in terms of 
having the honesty within ourselves and beginning, likely 
stumbling at first to have more honesty with our patients and 
families, at least when they asked us to do so. That was a real 
indication for us to do our best to communicate.  
[00:13:31] 
 Bryan Sisk: In the Awareness of Dying, I've heard that book come up from a 
couple of people. Is that a book that you think broadly impacted 
pediatric palliative care?  
 
                                                 
1 Strauss, A., & Glaser, B. (2005). Awareness of Dying. Aldine Transaction.  
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Pamela Hinds: You know it's interesting. It's a great question. I'm not sure that I 
know that it broadly affected care, but I know that it trickled down 
to my community hospital and then later my academic medical 
centers where I worked, because we did change care and care 
policies. I guess I can honestly say to you, I don’t know how 
broadly that affected care in that decade, but it certainly did affect 
the care settings that I practiced in.  
[00:14:18] 
 Bryan Sisk: Do you think that the clinicians, when they were tending or not 
tending to the child suffering, do you think there was a focus on 
individual symptoms, or do you think there was a holistic view of 
suffering or do you think there is just agnosticism about all of it?  
 
Pamela Hinds: I think that initially we really went after pain. I think we 
recognized that children were having pain. One of the early turning 
points for us was the work by Jo Eland and she was a real force. 
She was a nurse and she studied pain and believed that—in fact 
published in the area of the myths about pediatric pain. That helped 
to really turn things around, at least in nursing practice, but she 
really also worked closely with physician colleagues to say 
"children are having pain. It's unbearable and we are under treating 
them and you've got to change it." It became a real mantra in the 
70s, "We've got to treat child pain." 
 
That was coming from nurses and physicians and it did lead to new 
policies, changes in intrusive procedures, and then to the belief that 
pain was measurable. In the 1980s we started measuring pain by 
child reports and it became, I'm sure as you know, a standard and 
now is a JCHO [Joint Commission on Accreditation of Healthcare 
Organizations] standard, but if you're not measuring pain, you are 
not practicing—you don 't have a best practice. They can give you 
a formal recommendation that counts against you with surveys and 
in-between surveys. I think it's incredibly exciting to look back and 
see where we've come. At the time it seemed very slow, but 
definitely coming.  
[00:16:27] 
 Bryan Sisk: When you were beginning your work, finishing nursing school and 
going through emergency department and ICUs [intensive care 
units], what were the biggest challenges for caring for these 
suffering children with these serious illnesses?  
 
Pamela Hinds: We had so few tools to make it better. You had to witness the 
suffering because we could not give them relief. That meant, not 
only did you witness the child suffering; you witnessed the family 
suffering. You could do all that you had within you and there are 
many things that you can do to try to make a suffering child 
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comfortable. Certainly, pharmacologically was a primary effort, 
but we also tried to change, oh, my gosh, position, temperature, 
lighting, distraction, I mean everything we could think of from a 
non-pharmacologic stance to make a child comfortable or to get 
reprieve.  
 
Oh, boy, inducing sleep was just such a relief for all of us because 
it was so awful to witness the suffering that you just couldn't quiet. 
It just didn't stop. I think there was a lot of urgency. You know, 
"It's got to be better," was really a mantra. “It's got to be better.”  
[00:18:05] 
 Bryan Sisk: Obviously nurses are, at least today, are by the bedside much more 
frequently than physicians and I assume back several decades ago, 
physicians were probably less tied to computers that didn't exist 
and more with patients. But was there a difference between the 
awareness of the pain and suffering from the nurse's perspective 
and the doctor's perspective?  
 
Pamela Hinds: Yes, and I think it led to some tension, but some suffering was so 
overt, no one could miss it and we should always speak to any 
level of suffering. I feel that's part of what nursing contributes to a 
team through our presence and being able to give firsthand 
accounts of what we're seeing. Our other colleagues cannot be 
there. That's our job. And so we should be able to give detailed 
accounts of what we're seeing that's so believable, that we can 
make care better for that child. I think physicians and nurses will 
openly talk about and certainly we've documented that we are not 
always in synchrony.  
 
I don't think that's unusual and I don't think there's anything 
abnormal or wrong with that. I think it's how a team should 
function in keeping each other informed enough so that ultimately 
we get very close to being at the same place at the same time. 
What teams will often report to me is that it is the nurse who gets 
to a certain awareness first. It may be because the parent has said 
something to the nurse. It may be because of observations, and it is 
the nurse then who will say, "Have we had the conversation with 
this family yet?"  
 
It is the nurse who keeps bringing that very difficult point up, and 
physicians will explain to me that they are not ready at the same 
time that a nurse is, and they will say, "No, no, we still have other 
things – other treatments - that we are doing, and we really want to 
do these other things." I think that creates a tension and I've often 
wondered if that tension has a purpose. Instead of us ignoring it—
because it's hard – and certainly it is hard to deal with the tension – 
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speaking to it as part of being a team. It's like a tension in a family, 
it's hard. But instead of trying to work around it, we should address 
it because maybe there are clues about that child's status that are 
embedded in that tension, quite frankly.  
[00:20:47] 
 Bryan Sisk: Was there a hesitance of using opioids or stronger medications for 
pain in kids back when you were starting out?  
 
Pamela Hinds: Definitely. There was a clear sense that we only had data from 
adults that we were taking a huge risk in dosing children with what 
was deemed to be an adult drug. There was always the fear that we 
would kill the child through the medication because it was an adult 
drug and we didn't really know pediatric dosing. We had such fears 
about that, and I mean all of us – not at all limited to a single 
discipline but a fear shared by all of us. That made it urgent to try 
to address some of the very overt suffering that we were 
witnessing, and the parent was witnessing, too. We did try dosing 
that was previously untried. With adults even we were using 
incredibly high doses.  
[00:21:52] 
 Bryan Sisk: When did that start to change?  
 
Pamela Hinds: I would say the mid-90s was when I recognized that we had really 
turned the corner. Before then it was anecdotally unique cases, but 
I think by the mid-90s we were routinely using certain drugs 
because we did not have the adverse effects that we had feared. We 
didn't always get efficacy to the extent that we had wished either, 
but we didn't have the adverse outcomes that we had feared.  
[00:22:39] 
 Bryan Sisk: What was used for pain when there is concern about, I'm assuming, 
concern about morphine and things like that?  
 
Pamela Hinds: There was a concern about morphine, and it was a pronounced 
concern, but we did use it. We used it in relatively small doses at 
that time. Yeah.  
 
 Bryan Sisk: It was mainly the dosing that was smaller? 
 
Pamela Hinds: Very much so. Yeah. Of course, now we recognize that children 
can tolerate high doses. But we started out at miniscule doses. I 
think the disease, like leukemia was so aggressive because our 
treatments then were still being refined. We were making definite 
progress, protocol by protocol, but I think about the hesitancy that 
we had. We had such an aggressive form of disease and such overt 
pain, but we were really iteratively finding our way.  
[00:23:53] 
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 Bryan Sisk: Was there similar concern or hesitance with the toxic 
chemotherapies they were given?  
 
Pamela Hinds: No. I think that's a really interesting question. We recognized that 
that was all protocol-driven in pediatric oncology. We felt like we 
had a roadmap and having a roadmap really makes a difference, I 
believe, in our thinking. What really pleases me is tracking what 
we thought we saw as side effects of these new drugs that we were 
using in chemotherapy. It led to really great discussions amongst 
all members of the team. We nurses would bring forward our 
information from infusions as we were the ones who were giving 
the infusions in the rooms and we had made the careful 
observations. It was a great collaboration between nursing and 
medicine. It was really terrific.  
[00:25:03] 
Bryan Sisk: What about psychological and social needs? How were those 
viewed for the patients and the families back in let's say the early 
70s?  
 
Pamela Hinds: I think children were dying fairly quickly then, to be honest with 
you, and so we needed to have psychology involved at an earlier 
point than typically happened. That really did change with some of 
the work by Spinetta, about coping and the advantages of having a 
psychologist as a member of the care team. I would say by the 80s 
that was considered routine care. They really had to be embedded. 
At that time point children were surviving, and it was a very 
different prognostic situation.  
[00:25:58] 
 Bryan Sisk: In terms of the psychological and social, was that something that—
did it seem like most doctors were on board and advocating for that 
or more so that most doctors allowed the nurses and psychologists 
to pursue that? What was your sense of their view about that?  
 
Pamela Hinds: I really saw my physician colleagues welcoming that.  I didn't—
sometimes you would have another member of the team, like a 
nurse, make the suggestion, but I never saw—well, I rarely saw an 
attending refuse or say something that was negative. Very rarely.  
[00:26:45] 
Bryan Sisk: Then for these children, were they involved in their own care at 
that time?  
 
Pamela Hinds: Yes. Now this varied. [laughs] Quite frankly, it varied. 
Increasingly children were asking us questions, the nurses around 
the bedside, and increasingly waiting until their parent left the 
room to have a discussion. Yes, I would say to you that children 
were getting very involved and it really thrilled us as nurses about 
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that. I think there was also a societal shift of recognizing the 
importance of the child’s voice. Children were being invited into 
other kinds of conversations too.  
 
They were being recognized as more articulate and in research we 
were inviting children to rate symptoms, and to talk to us about 
their quality of life in the 1980s. If they could articulate about 
those topics, our reasoning was they could also articulate about 
end-of-life decision-making. A lot of that was really tied to our 
comfort in pursuing palliative and end-of-life research by seeking 
the child voice, became more possible because we had previously 
included them in symptom studies.  
[00:28:21] 
 Bryan Sisk: Do you think that societal shift was around the 80s at the same 
time or when do you think that occurred? 
 
Pamela Hinds: I do think it was around there. I do. I think the 80s and 90s were 
really quite significant family structure shifts and family 
inclusiveness and children had voices that they had not had before.  
[00:28:46] 
Bryan Sisk: When in your career did you understand that the things you were 
interested in were being called pediatric palliative care or 
pediatric—when did that phrasing and that kind of 
conceptualization of the things you were doing come to your 
mind?  
 
Pamela Hinds: Boy, it's a good question. Do I know? [laughs] Certainly, in the 
70s it was being used, but primarily for end of life. I went to St. 
Jude in '85 and was very involved in palliative and end of life care 
from the beginning. But it was in the 2000s when I approached 
hospital leadership about creating a palliative care service and 
defined it using the academy's definition ‘from the point of 
diagnosis of a very serious or life threatening illness’. This was not 
the first time that someone had approached the hospital leadership 
about creating this kind of service, but I think our timing was 
better because we had done research in the area and that was the 
dominant culture there.  
 
If you could get external funding for an area of science, must be it 
was worth doing! We had had some very good luck in getting that 
funding. Then I got appointed to the Institute of Medicine's 
committee on Children Dying in America and that really—and I 
had a very supportive physician colleague, Dr. Joe Mirro who was 
the chief medical officer at St. Jude and I will always credit him 
with having supported my participation in that committee work. I 
said to him, "You know, if I accept this invitation, I'm going to 
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have to indicate to them that we do not have a palliative care 
service." He said, "Oh, but do it anyhow." That experience plus 
others really helped us to create that service and to begin research 
in this area, and that included end-of -life decision-making from 
the child's perspective, including from the child that was dying. It 
was really very exciting; exciting days.  
[00:31:24] 
 Bryan Sisk: In thinking back to end of life, another question I had about your 
earlier experiences, what was the presence of the clinical team 
members around the end of life? Were there people around or 
where they avoidant? Can you tell me a little more about that?  
 
Pamela Hinds: I think initially it wasn't so much avoidance, it was trying to be 
thoughtful of the family. The assumption was that we should leave 
them as much to themselves as we could and many of these 
children, many, died in the hospital. This followed of course, Ida 
Martinson's groundbreaking work2 where she clearly taught us that 
children could die at home, that it was very acceptable to families, 
physicians and nurses involved in that model. Others since then, 
building on that work have taught us about the cost of that care. I 
would say initially it was probably just uncomfortableness, but 
primarily wanting to do what the families might want us to do. We 
often did that without asking the family. It was an assumption and 
it was only later that we really started asking, "What would you 
like? How can we best do this for you?" I think it took us a while 
to find our way. I think instead of talking about something, we 
primarily thought, "How would my family want this done?" We 
got very careful, truthful.  
[00:33:06] 
 Bryan Sisk: Have you seen that change over time, or has it changed in some 
pockets and not in others?  
 
Pamela Hinds: I think it's definitely changed. We talk much more openly with 
each other as a team and we will ask families, how would you like 
this to be? I think it's very different. 
[00:33:25] 
 Bryan Sisk: As you were getting your experience in critical care and 
emergency medicine to try to get the skills you needed to do this 
career, what were the biggest challenges you faced as you tried to 
build this palliative care career?  
 
Pamela Hinds: Credibility amongst other services, soothing fears that a palliative 
care service would step in and interfere with their relationship long 
established with a child in a family. I think we underestimate that 
                                                 
2 Martinson, I., Armstrong, G.D., Geis, D.P., Anglim, M.A., Gronseth, E.C., MacInnis, H., Kersey, J.H., 
Nesbut, M.E. Home care for children dying of cancer. Pediatrics, Vol 62(1), 106-113.  
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anxiety in our good colleagues. That continues to be a real anxiety. 
Are we going to sever, replace, someone who's really had a very 
important relationship with the family already? I think then for me 
additionally was the challenge of finding research funding for this 
kind of work because we knew that we didn't know what we 
needed to know and that we needed to do research to learn 
firsthand from these children and their parents and each other 
about what we could do.  
 
I think professional courage is part of this story for all of us finding 
our way. Being confident that if in fact we erred, and you'll always 
hear us talk about not wanting to do harm. If we erred, that we had 
the skills and the relationship to correct what we might've done and 
start again.  
[00:35:20] 
Bryan Sisk: How do you think these developing palliative care teams, how do 
you think they were initially viewed by the pediatric patients 
themselves?  
 
Pamela Hinds: With caution. I think they liked the people on the team, but it was 
another team. It was clear it was a different focused team. I think, 
and I mean that from the family perspective primarily, just 
cautious like, "What is this?" But I have seen stellar relationships 
evolve between a palliative care team and another specialty care 
team and between the palliative care team, the family, including all 
members. It has been an evolution and a lot of it is being able to 
self-describe what we do, answering to uneasiness to others, and 
being very mindful about what our presence does to the presence 
of others.  
[00:36:30] 
 Bryan Sisk: You had mentioned research funding which is I guess for everyone 
is an ongoing challenge, but probably was a lot worse back then.  
 
Pamela Hinds: [laughs] It was. There was no strong interest at NIH [National 
Institute of Health] initially in this kind of research. Our early 
funding was from oh, gosh, The Project on Death in America.3 
Quite a name, and this philanthropist really did get several of us 
started, Joanne Hilden, Joanne Wolf and I were all funded through 
this mechanism. From there I went on to NIH for funding, but I 
credit that philanthropist in getting us all started.  
[00:37:21] 
 Bryan Sisk: When did NIH start to develop an appetite for this type of 
research?  
 
                                                 
3 Soros, G., Foley, K. Project on Death in America. Open Society Institute. New York. 
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Pamela Hinds: I guess it again depends upon how we define palliative care, 
because certainly there was pain research funded by NIH for 
decades. Very notably in the previous decade NIH took note of the 
importance of palliative care in the broadest sense and including 
end-of-life care and that they should be involved in funding 
research. The mandate went out for this kind of research to be 
funded. The home for that was of course the National Institute of 
Nursing Research and the office is there, but other institute can co-
fund this kind of research. What's good about having an office 
within an institute is that funding mechanisms are coming forth as 
well visionary thinking and planning.  
 
They've had new ones this year, several in 2018, 2017, 2016, 
further back. It's really significant for us that the NIH has this 
office. Now it frustrates people because the overall funding of 
something that is overtly labeled "palliative" and "end-of-life 
research," is a very small percentage of the overall budget. That’s 
factual. But if you look at the broader definition of palliative care, 
a fair amount more would be noted. It's not by any means 
anywhere near the amount of dollars being put into cure-oriented 
research, but it does have a foothold and it has very passionate and 
dedicated individuals who are leading that office.  
[00:39:20] 
 Bryan Sisk: From your perspective, what drove the development of pediatric 
palliative care as its own specialty?  
 
Pamela Hinds: Need. I think there was clearly a need that was recognized, had its 
own body of knowledge and it had passionate and committed 
people who wanted to make that their career. I would say I think 
need was really the driving force.  
 
 Bryan Sisk: Who do you think was recognizing that need?  
 
Pamela Hinds: Families initially, and so I think part of the reason that Jo Eland 
was so successful in the 70s, and Ida Martinson in the 70s and 80s, 
was that they aligned with parents, parents whose children had 
suffered and died. They were determined not to have this happen 
again. It isn't just those two individuals, but what was so 
significant of course was that they aligned so well with a care 
recipient or consumer. I would say I believe that when a health 
care professional aligns well with families, they're unbeatable. 
They're absolutely unbeatable. Both of them took these models 
internationally and that also influenced how far we could go with 
this work.  
[00:40:55] 
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 Bryan Sisk: Then along that path, what do you think were the biggest 
challenges as it was developing into a specialty?  
 
Pamela Hinds: I would go back again to credibility and the fear of severing or 
interfering with relationships with others, building that body of 
knowledge. Publishing original research took a while. When we 
first did the Institute of Medicine's 2003 report,4 so we started that 
in 2001,5 there was very little research and we were citing what's 
considered classic and older work. A lot of that book was 
anecdotal, experiential report, national statistics on children, the 
causes of death, but not much research on symptom management 
and the actual dying.  
 
Then fast forward to that 2015 report,6 as we were bringing in 
evidence, two of the leaders for that working committee said "You 
probably want to have a special section called "Other" and have all 
the pediatric data there." I said, "No, no, we are way beyond that. 
We have enough data now for every section to reflect pediatrics." 
That was a huge step forward for us to be able to say that. My hope 
is that we will have another report in another seven to ten years 
and it will be so substantial. It may be a freestanding pediatric 
report based on evidence.  
[00:42:47] 
 Bryan Sisk: Wow, that would be a dream.  
 
Pamela Hinds: It would be, yes. It really would be. You said something really 
significant today in our previous conversation about discourse, 
needing to have discourse. I would  support you in that statement, 
but what I would say to you is what we know is that as palliative 
care specialists, we are not as skilled with public discourse as 
people such as a Sarah Palin, who really grabbed the public 
attention so thoroughly, so incorrectly, that the Affordable Care 
Act had to drop the sections related to hospice and palliative care. 
She did it by using that phrase, "death panel." She was absolutely 
wrong. It was declared the greatest lie of the year, but very 
effectively destroyed that part of the bill. 
 
We in turn were not effective in countering her approach. We've 
got to learn to do that. We've got to have public discourse about 
dying, about suffering and we've got to be able to do it in a way 
                                                 
4 Long, K. (2003). The Institute of Medicine Report: Health Professions Education: A Bridge to Quality. 
National Institutes of Medicine. Washington, D.C.: National Academy Press. 
5 Institute of Medicine (2001). Crossing the quality chasm: A new health system for the 21st century. 
Washington, D.C.: National Academy Press. 
6 Institute of Medicine (2015). Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk. 
Washington, D.C.: National Academy Press. 
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that our voice can be heard above a politicians voice or any other 
person's voice that is frankly, blatantly incorrect and alarmist. We 
have not yet mastered that.  
 
 Bryan Sisk: I agree. That's a pervasive problem for really all of science.  
 
Pamela Hinds: I would agree with you absolutely. 
[00:44:39] 
 Bryan Sisk: How much do you think the adult hospice and palliative movement 
affected the development of pediatric palliative care?  
 
Pamela Hinds: Oh, I think we owe them a lot. [laughs] I'm very grateful to them. 
In fact, I often think that we ought not to try to distinguish 
ourselves too, too much and we always say a child's not a little 
adult. Of course, that's true, but I also think we can learn much 
from our adult follies and given that we have such a much-reduced 
population. We would possibility prevent ourselves from learning 
something if we didn't join forces with them in some ways. Better 
for us to really test what’s different and what's the same in children 
adults than just a claim that there's no similarity, I think.  
[00:45:34] 
 Bryan Sisk: Were there any negative influences? I guess any problems or 
barriers that were created from the adult hospice movement on the 
development of pediatric palliative care.  
 
Pamela Hinds: Really none that I know of, but I would say they were more 
advanced than we were. They had a head start and so we do have 
to compete funding wise when I think about NIH. Yeah, so it's fair 
I guess to say that there is that to be said. I've never sensed 
interference or competition.  
[00:46:17] 
 Bryan Sisk: When you look over your career, what do you think have been the 
biggest changes in the care that we provide for these suffering 
children?  
 
Pamela Hinds: Oh, gosh. I'm  thinking of it in several categories. We really do see 
it as family centered care and so all family members are much 
more intricately involved with the care than ever before, so that's a 
real advance. We really have advanced through technology with 
care intervention. I know I mentioned terminal sedation to you in a 
comment earlier today. That's clearly an act out of desperation, but 
it wasn't an option.  
 
There was no such option to really go after what is eluding us, and 
I don't think that's the greatest example of technology, believe me, 
but there are repeated examples of where we now recognize and 
Interviewer:  Bryan Sisk  July 19, 2019 
Interviewee:  Pamela Hinds  Page 18 of 20 
 
 
   
intervene with symptoms broadly stated. It isn't just pain. We're 
going after something that we would've said decades ago was 
unimportant, that's fatigue. What can we do to help a child who's 
overwhelmingly experiencing fatigue and can no longer achieve 
developmental milestones? We think about that now and I don't 
think—I know we didn’t think about that years ago. We were not 
thinking like that.  
 
I think the other category where we are very different is 
communication. No longer do we have those orders written, "Do 
not tell the diagnosis, do not speak." We know that we wouldn't do 
that. That we would be responsive and listen well and honor the 
child's voice, so I think it's quite different over the decades.  
[00:48:19] 
 Bryan Sisk: You have a voluminous body of work, so how do you think your 
work contributed to these changes?  
 
Pamela Hinds: Oh, now that I'm probably not going to be so good about. I really 
don't know. I'm not sure Bryan. It's a fair question, probably one 
that I don't reflect on because I think instead of how much we have 
left to do. I'm excited about all that we have left to do. We have 
quite a bit. It's good that you make us look backwards and I often 
say that here. We should look back because if we don't, we won't 
see how far we've come. Looking back sometimes gives you 
clarity on what you've got to do next. I guess I should think about 
that a little bit more than I have.  
[00:49:15] 
 Bryan Sisk: What do you think, looking at the field where it sits now, what do 
you think are the biggest challenges that we face right now?  
 
Pamela Hinds: I think credibility remains a challenge. Building the field both with 
knowledge and numbers is essential. Research funding you will 
always hear us say is so, so needed. It is, but I feel as a young field, 
we have more going for us than many other fields and part of that 
is the interprofessional approach. It's well-established in this 
specialty are and there are older specialties where it is not, and I 
wish it could be because it makes such a difference.  
[00:50:27] 
 Bryan Sisk: What do you think the field really needs to grow?  
 
Pamela Hinds: I think technology will always remain a need for us. I think the 
work with communication is essential. I feel very good about the 
focus made on both. I think policy is gonna be essential for us and 
though not a ‘first thought’ for us, if we're going to have public 
discourse about what is needed, we've got to be better at public 
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discourse. That means being well prepped for it and seeking 
opportunities to engage the public in these kinds of discussions.  
[00:51:23] 
 Bryan Sisk: What do you think are the strongest areas of the field currently?  
 
Pamela Hinds: I do think collaboration across settings is very strong. I do think 
the relationship between the clinical investigators and the Office of 
End of Life Research is very strong and waiting to be built more. 
We have such champions there and they really just need our 
support in order to do that. I think I would go with policy as where 
I'm sure we've got more work to do.  
[00:52:22] 
 Bryan Sisk: Lastly, I just want you to dream aloud for me. If budget and 
politics and Sarah Palin's, and all these other things were no 
obstacle, what would you want care for these children to look like 
in another ten years?  
 
Pamela Hinds: I would want for these children to be able to choose the location of 
their care and that we could fully meet their choice. They know 
where they thrive, and there are some children who choose hospital 
care. I would like that to be a choice. I would like our care to be so 
present, so effective that our families will not feel alone. I would 
like our care to be so effective, for the time that we have them with 
us that they never forget that, that they know that we believe in 
them, that they were good parents, and that they did something 
really remarkable for that child.  
[00:53:44] 
 Bryan Sisk: Beautiful. Well, that's the end of my questions. Is there anything 
else about this history that you wanna tell me about or you think 
that I might have missed over?  
 
Pamela Hinds: You know, the only thing that I might mention is that along the 
way, different disciplines, including nursing, created position 
papers, standards of practice, scope of practice, all related to 
palliative and end of life. I think that's so excellent that the 
disciplines formalize their support in ways that are meant to guide 
practice. It's the official sanctioning and so I think that's important 
to note and some of those position papers were very much about 
managing pain and the ethics of intervention. Certainly, for 
nursing, we began those in the 2000s, early 2000s. I don't know the 
start date for similar kinds of things in medicine, but I think the 
American Academy of Pediatrics has something very similar as I 
go over their position statements. I think that's worth mentioning.  
 
 Bryan Sisk: Anything else?  
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Pamela Hinds: That's perfect and I so appreciate you going after this. Keep right 
on going Bryan. You're doing important work.  
 
[End of Audio] 
